Terms: = Breast cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105 AND Prognosis
72 results:
1. The role of transcription factor foxa1/C2/M1/O3/P1/Q1 in breast cancer.
Yuan H; Liang Y; Hu S; Chen J; You J; Jiang J; Luo M; Zeng M
Medicine (Baltimore); 2024 Apr; 103(15):e37709. PubMed ID: 38608123
[TBL] [Abstract] [Full Text] [Related]
2. Staufen1 Represses the foxa1-Regulated Transcriptome by Destabilizing foxa1 mRNA in Colorectal cancer Cells.
Pasterczyk KR; Li XL; Singh R; Zibitt MS; Hartford CCR; Pongor L; Jenkins LM; Hu Y; Zhao PX; Muys BR; Kumar S; Roper N; Aladjem MI; Pommier Y; Grammatikakis I; Lal A
Mol Cell Biol; 2024; 44(2):43-56. PubMed ID: 38347726
[TBL] [Abstract] [Full Text] [Related]
3. Deciphering the Immune Microenvironment at the Forefront of Tumor Aggressiveness by Constructing a Regulatory Network with Single-Cell and Spatial Transcriptomic Data.
Xu K; Yu D; Zhang S; Chen L; Liu Z; Xie L
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254989
[TBL] [Abstract] [Full Text] [Related]
4. Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature.
Gonzalez T; Nie Q; Chaudhary LN; Basel D; Reddi HV
Cancer Genet; 2024 Apr; 282-283():1-8. PubMed ID: 38134587
[TBL] [Abstract] [Full Text] [Related]
5. AGR2 and foxa1 as prognostic markers in ER-positive breast cancer.
Zhou M; Gan XL; Ren YX; Chen QX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
BMC Cancer; 2023 Aug; 23(1):743. PubMed ID: 37568077
[TBL] [Abstract] [Full Text] [Related]
6. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative breast cancer.
Liu Y; Fang Y; Bao L; Wu F; Wang S; Hao S
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291687
[TBL] [Abstract] [Full Text] [Related]
7. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC.
Guo Q; Qiu P; Yao Q; Chen J; Lin J
Dis Markers; 2022; 2022():4964793. PubMed ID: 36157217
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS; Chen G; Liu J; Tang D; Zheng JH; Luo J; Jin MH; Lu HS; Bao CX; Tian J; Deng WS; Fu JW; Feng Y; Zeng NY; Zhou HF; Kong JL
BMC Pulm Med; 2022 Jun; 22(1):246. PubMed ID: 35751045
[TBL] [Abstract] [Full Text] [Related]
9. 2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity.
Kusi M; Zand M; Lin LL; Chen M; Lopez A; Lin CL; Wang CM; Lucio ND; Kirma NB; Ruan J; Huang TH; Mitsuya K
Cell Rep; 2022 Jan; 38(2):110220. PubMed ID: 35021081
[TBL] [Abstract] [Full Text] [Related]
10. ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway.
Lin Y; Li C; Xiong W; Fan L; Pan H; Li Y
Cell Death Dis; 2021 Nov; 12(11):1042. PubMed ID: 34725332
[TBL] [Abstract] [Full Text] [Related]
11. The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status.
Horisawa N; Adachi Y; Takatsuka D; Nozawa K; Endo Y; Ozaki Y; Sugino K; Kataoka A; Kotani H; Yoshimura A; Hattori M; Sawaki M; Iwata H
Breast Cancer; 2022 Mar; 29(2):234-241. PubMed ID: 34622383
[TBL] [Abstract] [Full Text] [Related]
12. prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate cancer.
Aggarwal R; Rydzewski NR; Zhang L; Foye A; Kim W; Helzer KT; Bakhtiar H; Chang SL; Perry MD; Gleave M; Reiter RE; Huang J; Evans CP; Alumkal JJ; Lang JM; Yu M; Quigley DA; Sjöström M; Small EJ; Feng FY; Zhao SG
JAMA Oncol; 2021 Nov; 7(11):1644-1652. PubMed ID: 34554200
[TBL] [Abstract] [Full Text] [Related]
13. Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer.
Abdelhafiz AS; Fouda MA; Elzefzafy NA; Taha II; Mohemmed OM; Alieldin NH; Toony I; Abdel Wahab AA; Farahat IG
Ann Diagn Pathol; 2021 Dec; 55():151814. PubMed ID: 34517157
[TBL] [Abstract] [Full Text] [Related]
14. Time-varying effects of foxa1 on breast cancer prognosis.
Chen QX; Yang YZ; Liang ZZ; Chen JL; Li YL; Huang ZY; Weng ZJ; Zhang XF; Guan JX; Tang LY; Yun JP; Ren ZF
Breast Cancer Res Treat; 2021 Jun; 187(3):867-875. PubMed ID: 33604715
[TBL] [Abstract] [Full Text] [Related]
15. [Regulation of IL33 Gene Expression by SP1 and foxa1 in breast and Lung cancer Cells].
Gorbacheva AM; Kuprash DV; Mitkin NA
Mol Biol (Mosk); 2021; 55(1):107-117. PubMed ID: 33566030
[TBL] [Abstract] [Full Text] [Related]
16. MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Petrelli A; Bellomo SE; Sarotto I; Kubatzki F; Sgandurra P; Maggiorotto F; Di Virgilio MR; Ponzone R; Geuna E; Galizia D; Nuzzo AM; Medico E; Miglio U; Berrino E; Venesio T; Ribisi S; Provero P; Sapino A; Giordano S; Montemurro F
ESMO Open; 2020 Oct; 5(5):e000937. PubMed ID: 33122354
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates foxa1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
18. Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients.
Govindan S; Siraganahalli Eswaraiah M; Basavaraj C; Adinarayan M; Sankaran S; Bakre M
BMC Cancer; 2020 Aug; 20(1):745. PubMed ID: 32778063
[TBL] [Abstract] [Full Text] [Related]
19. Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative breast cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions.
Kubouchi K; Shimada K; Yokoe T; Tsutsumi Y
Technol Cancer Res Treat; 2020; 19():1533033820943246. PubMed ID: 32677589
[TBL] [Abstract] [Full Text] [Related]
20. Roles and correlation of foxa1 and ZIC1 in breast cancer.
Zhang YW; Ma J; Shi CT; Han W; Gao XJ; Zhou MH; Ding HZ; Wang HN
Curr Probl Cancer; 2020 Oct; 44(5):100559. PubMed ID: 32115254
[TBL] [Abstract] [Full Text] [Related]
[Next]
